Brain insulin lowers circulating BCAA levels by inducing hepatic BCAA catabolism. - Wikidata - awgldk - TriplyDB

Brain insulin lowers circulating BCAA levels by inducing hepatic BCAA catabolism.

Brain insulin lowers circulating BCAA levels by inducing hepatic BCAA catabolism.

http://www.wikidata.org/entity/Q34624088

about

The Emerging Role of Branched-Chain Amino Acids in Insulin Resistance and Metabolism Branched-chain amino acid catabolism is a conserved regulator of physiological ageing.The Relationship between Branched-Chain Amino Acid Related Metabolomic Signature and Insulin Resistance: A Systematic Review Branched-chain amino acids in metabolic signalling and insulin resistance Branched-chain amino acid restriction in Zucker-fatty rats improves muscle insulin sensitivity by enhancing efficiency of fatty acid oxidation and acyl-glycine export Metabolite profiling in plasma and tissues of ob/ob and db/db mice identifies novel markers of obesity and type 2 diabetes.Uric Acid Produces an Inflammatory Response through Activation of NF-κB in the Hypothalamus: Implications for the Pathogenesis of Metabolic Disorders Genetic Predisposition to an Impaired Metabolism of the Branched-Chain Amino Acids and Risk of Type 2 Diabetes: A Mendelian Randomisation Analysis.Global deletion of BCATm increases expression of skeletal muscle genes associated with protein turnover NMR-based metabolic profiling in healthy individuals overfed different types of fat: links to changes in liver fat accumulation and lean tissue mass.The positive association of branched-chain amino acids and metabolic dyslipidemia in Chinese Han population.Defects in muscle branched-chain amino acid oxidation contribute to impaired lipid metabolism Insulin Receptor Signaling in POMC, but Not AgRP, Neurons Controls Adipose Tissue Insulin Action.What Have Metabolomics Approaches Taught Us About Type 2 Diabetes?Increased susceptibility to metabolic dysregulation in a mouse model of Alzheimer's disease is associated with impaired hypothalamic insulin signaling and elevated BCAA levels.Effect of acute ozone exposure on the lung metabolomes of obese and lean mice.Serum and plasma amino acids as markers of prediabetes, insulin resistance, and incident diabetes.Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums.Chronic Diseases and Lifestyle Biomarkers Identification by Metabolomics.Using Metabolomics to Explore the Role of Postmenopausal Adiposity in Breast Cancer Risk.A Metabolomics Analysis of Body Mass Index and Postmenopausal Breast Cancer Risk.Plasma Amino Acids vs Conventional Predictors of Insulin Resistance Measured by the Hyperinsulinemic Clamp.Metabolic adaptations to HFHS overfeeding: how whole body and tissues postprandial metabolic flexibility adapt in Yucatan mini-pigs.The BCKDH Kinase and Phosphatase Integrate BCAA and Lipid Metabolism via Regulation of ATP-Citrate Lyase.Acylcarnitine Profiles in Plasma and Tissues of Hyperglycemic NZO Mice Correlate with Metabolite Changes of Human Diabetes.

P2860

Q26744725-D855FB84-AB2C-4E36-B59A-CED455FCD3EA Q27342729-858F7ADF-2C00-4CFB-BB40-12B4D5D2C6ED Q28069578-4CFE042A-7F18-4076-96CC-6DEB84254337 Q28249276-BFC17A3D-2E6D-41ED-84B6-C054FCB2F09A Q29306550-DA290428-2D5D-4322-9C4A-41C7044AF713 Q35658650-9E6623A1-9F1D-454A-8783-B5A9BBCBAB25 Q35856483-22250A38-3B33-4933-AC5A-B538E6F70E11 Q36206751-4D788011-51CC-49C5-B647-5724911B15D5 Q36237292-380C6190-5089-45AA-8FC6-9ADB04DFE877 Q36245518-173313C9-737A-4E8C-AE88-B098FEE4E2D4 Q37125652-A23CFFD0-6CDB-4777-BFD9-2B58DFA68780 Q37278842-0A543F7A-888B-499D-A8AE-CE7FAAE28C1D Q38849153-AC79AA63-5342-4224-A797-9B32B9B8C0D5 Q38851257-483DFAC3-9C70-4723-A68D-4F2A3B98BCB2 Q39958782-817C0B1B-0E17-436A-BDB6-334B1AC8F967 Q41007154-380DD111-92F9-4403-8D0A-140386526F85 Q47312518-806AFF63-C9FB-475A-A7D7-A176E44BFAE7 Q47835103-5B7A5710-388B-4A6B-8A34-3606EEDC8CDA Q47987782-6A9E379A-DFFA-4487-BD9C-B84E11EDED87 Q50084039-1A255D76-BAD8-4FA8-8203-CD8F2DBE686A Q50084091-B85CFE2A-FB1C-44F8-9234-1FD8036FB69C Q51249812-1214DB86-DADE-42E2-95E0-5A32549D0F05 Q51835057-51395325-825E-44B8-BB36-46EED717C939 Q54108559-70AECBF3-68C2-40F5-89FC-8280F6513087 Q55287185-1068C168-99BD-41D4-BF01-CDAFCEA702E9

P2860

Brain insulin lowers circulating BCAA levels by inducing hepatic BCAA catabolism.

http://www.wikidata.org/entity/Q34624088

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Brain insulin lowers circulating BCAA levels by inducing hepatic BCAA catabolism.

@ast

Brain insulin lowers circulating BCAA levels by inducing hepatic BCAA catabolism.

@en

Brain insulin lowers circulating BCAA levels by inducing hepatic BCAA catabolism.

@nl

type

label

Brain insulin lowers circulating BCAA levels by inducing hepatic BCAA catabolism.

@ast

Brain insulin lowers circulating BCAA levels by inducing hepatic BCAA catabolism.

@en

Brain insulin lowers circulating BCAA levels by inducing hepatic BCAA catabolism.

@nl

prefLabel

Brain insulin lowers circulating BCAA levels by inducing hepatic BCAA catabolism.

@ast

Brain insulin lowers circulating BCAA levels by inducing hepatic BCAA catabolism.

@en

Brain insulin lowers circulating BCAA levels by inducing hepatic BCAA catabolism.

@nl

P1433

Q34624088-938EFCF6-BF76-452B-80EE-732063D32D60

P1476

Q34624088-BB80EA57-776B-423A-863F-A4C31708D4FE

P2093

Q34624088-084A750F-8FC5-4432-AC53-C251B81A01BD

Q34624088-192A9127-490E-46C3-90D7-3005743F8522

Q34624088-1D431CBE-67AC-4497-B620-61CF3F2D50D7

Q34624088-36B750AD-C599-411C-A12D-C8EA82BB4EBD

Q34624088-3BEB14E9-D132-49AE-BFD7-FD88FFFC4078

Q34624088-456D54A5-0A0C-4A77-AEE7-0597808CA93E

Q34624088-4FB95084-8D88-4C6B-B9EF-A232DDEB510A

Q34624088-A0276B78-53F2-4FEB-9576-D52CB231FECB

Q34624088-A2E9FAEA-6D8F-4E2C-95CE-6FAA6E304F4E

Q34624088-BD2D7AEE-5E09-4CD8-9C3D-16A818C3D3B8

P2860

Q34624088-166B6C45-6727-4FCF-B0F6-0B9A32C39851

Q34624088-17AC95AB-A4E2-46BE-8F3D-C5F0BD9F9904

Q34624088-244C7D9E-4D3C-4295-A66B-86170FE369A5

Q34624088-27B21585-1822-4BC8-ACD3-1CD02E01BD20

Q34624088-29ABEE69-56AA-407C-84B8-D58DF0DC1AAD

Q34624088-2A17E96D-DAC8-4569-93A1-3897A4BE7FE8

Q34624088-2DE2FAC5-8F20-468D-B560-4AA4BCC803E4

Q34624088-33D97B08-4FF9-49F8-AC21-458E2AD71BCF

Q34624088-367986BE-5C90-44C2-AD37-DAED08FFFC42

Q34624088-3C0CFB9C-8D23-4885-9A99-5AD8BA355221

P304

Q34624088-CBE11BE3-9789-4C0A-8277-FCE20E161D36

P31

Q34624088-29A4ADF1-3F65-45A8-9BAF-8775B72A6659

P356

Q34624088-E1978123-5BDE-4963-80BC-1A94019FA573

P433

Q34624088-21DC791F-B8AD-4A88-8F97-76568EE31D8B

P478

Q34624088-78D563D7-8B8D-4728-A006-0F644A5F0561

P50

Q34624088-2BC136FC-8E9E-47D7-84F2-68415761818A

Q34624088-92668CC4-D2B4-4F79-9BA2-8868A457394A

P577

Q34624088-336B6B94-EF45-48E4-8E87-F8698F8D4F34

P5875

Q34624088-DB4F8D98-5E1E-4922-AEF0-402B8D8DD834

P698

Q34624088-B9175234-4AC4-4E06-9FCF-F2DBA6FDE569

P921

Q34624088-8120000E-2046-466D-9207-B17B1AB23000

P932

Q34624088-D5E1F42A-1DF9-4531-9D1C-54F863CFC0B1

P356

J.CMET.2014.09.003

P1433

Cell Metabolism

P1476

Brain insulin lowers circulating BCAA levels by inducing hepatic BCAA catabolism

@en

P2093

Amanda L Lapworth

http://www.w3.org/2001/XMLSchema#string

Andrew C Shin

http://www.w3.org/2001/XMLSchema#string

Anna M Wolf

http://www.w3.org/2001/XMLSchema#string

Christoph Buettner

http://www.w3.org/2001/XMLSchema#string

Christopher B Newgard

http://www.w3.org/2001/XMLSchema#string

Christopher J Lynch

http://www.w3.org/2001/XMLSchema#string

Claudia Lindtner

http://www.w3.org/2001/XMLSchema#string

Elizabeth Zielinski

http://www.w3.org/2001/XMLSchema#string

Jian-Ying Zhou

http://www.w3.org/2001/XMLSchema#string

Kevin L Grove

http://www.w3.org/2001/XMLSchema#string

P2860

Leptin therapy in insulin-deficient type I diabetes

A C. elegans mutant that lives twice as long as wild type

Hypothalamic mTOR signaling regulates food intake

A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance

Branched-chain amino acid metabolism

Metabolite profiles and the risk of developing diabetes

Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes

Genetic networks of liver metabolism revealed by integration of metabolic and transcriptional profiling.

Metabolic profiling of plasma in overweight/obese and lean men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC-Q-TOF MS).

Brain insulin action regulates hypothalamic glucose sensing and the counterregulatory response to hypoglycemia

P304

898-909

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CMET.2014.09.003

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Phillip J. White

P577

2014-10-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266731254

http://www.w3.org/2001/XMLSchema#string

P698

25307860

http://www.w3.org/2001/XMLSchema#string

P921

P932

4254305

http://www.w3.org/2001/XMLSchema#string